	Serum neutrophil gelatinase-associated lipocalin as a potential signature for acute generalized exanthematous pustulosis and generalized pustular psoriasis: A case-control study. JAAD Int Shou Y, Zhang M. PMID: 41439016 [PubMed]
	Antibodies Targeting Gasdermin E as a Potential Therapeutic Option for Psoriasis - A Pilot Study on a Mouse Model. Psoriasis (Auckl) Nowowiejska-Purpurowicz J, Hermanowicz JM, Pawlak D, Flisiak I, Lipinski T. PMID: 41438421 [PubMed]
	Assessing internal construct validity of DAPSA and DAPSA28 in psoriatic arthritis: a European observational study using confirmatory factor analysis and additional psychometric testing. RMD Open Jørgensen JB, Christensen KB, Michelsen B, Loft AG, Horskjær Rasmussen S, Heberg J, Hetland ML, Zavada J, Pavelka K, Iannone F, Conti F, Borges J, Codreanu C, Mogosan C, Glintborg B, Ciurea A, Nissen MJ, Nordström D, Kuusalo L, Laas K, Vorobjov S, Gudbjornsson B, Love TJ, Østergaard M, Ørnbjerg LM. PMID: 41436138 [PubMed - indexed for MEDLINE]
	Evaluating the Body Roundness Index as a Novel Digital Biomarker for Psoriasis Risk Prediction: Cross-Sectional Study. JMIR Med Inform Wen P, Wang X, Zhuo X, Xue S. PMID: 41432618 [PubMed - indexed for MEDLINE]
	Interface-Engineered Nanocarriers for Translational and Patient-Centric Topical Therapy in Psoriasis. Drug Dev Res Singh V, Rehman U, Alqahtani T, Shmrany HA, Gupta G, Goh KW, Kesharwani P. PMID: 41431180 [PubMed - indexed for MEDLINE]
	Immunogenicity of Biosimilar Therapies for Psoriasis in Head-to-Head Trials. J Am Acad Dermatol Smith LR, Feldman SR. PMID: 41429207 [PubMed - as supplied by publisher]
	Neuroimmune Crosstalk in Psoriasis: Mechanisms and Therapeutic Implications. Inflammation Gao H, Fang Y, Zhang Y, Xie T, Chen Z, Wang G. PMID: 41428266 [PubMed - in process]
	Late-onset psoriatic arthritis: data from a nationwide cross-sectional study. Ther Adv Musculoskelet Dis Karagianni S, Eleftheraki A, Papagoras C, Gazi S, Mole E, Krikelis M, Voulgari PV, Kaltsonoudis E, Koletsos N, Boumpas D, Katsimpri P, Katsifis-Nezis D, Dimitroulas T, Kougkas N, Sfikakis PP, Tektonidou MG, Vassilakis KD, Bogdanos D, Simopoulou T, Koutsianas C, Mavrea E, Katsifis G, Kottas K, Konsta M, Tziafalia M, Kataxaki E, Kalavri E, Klavdianou K, Karamanakos A, Xynogalas I, Daoussis D, Iliopoulos G, Bournazos I, Georganas C, Patrikos D, Vassilopoulos D, Fragoulis GE. PMID: 41427120 [PubMed]
	Psoriasis and gut microbes: research advances from mechanism to therapy. Front Microbiol Chen J, Sun K, Zhang X, Chen X, Chu Y, Geng L, Bian Z, Su Y, Cong X, Wang G. PMID: 41425939 [PubMed]
	Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis. JCI Insight Strawn D, Krueger JG, Bissonnette R, Eyerich K, Ferris LK, Paller AS, Pinter A, Richards D, Chen EY, Paget K, Horowitz D, Parast R, Rusbuldt JJ, Sendecki J, Bhagat S, Tomsho LP, Chou CH, Polak ME, Keyes BE, Bozenhardt E, Xiong Y, Zhou W, DeKlotz C, Newbold P, Waterworth DM, Miller M, Ota T, Yang YW, Leung MW, Miller LS, Cuff CA, McRae B, Ruane D, Kannan AK. PMID: 41424381 [PubMed - indexed for MEDLINE]
	Certolizumab-associated autoimmune-like hepatitis. BMJ Case Rep Peggie E, Shetty S, Johnston M, May C, Oien K, Kohnen G. PMID: 41423287 [PubMed - indexed for MEDLINE]
	Relation between gut microbiome and inflammatory interleukins in psoriasis patients compared to healthy controls: an observational study. Actas Dermosifiliogr Schneller-Pavelescu L, Mora-Martínez C, Sánchez-Pujol MJ, Sanz Y, Caparrós-Cayuela E, Francés-Guarinos R, Ramos-Rincón JM, Belinchón-Romero I. PMID: 41421479 [PubMed - as supplied by publisher]
	Cancer Progression, Recurrence, and Infection Outcomes in Psoriasis Patients with Active or Recent Malignancy Treated with Biologic Therapy: A Cohort Study Showing Comparable Safety to Conventional Agents. J Am Acad Dermatol Bar D, Brilant L, Lidar M, Barzilai A, Baum S. PMID: 41419137 [PubMed - as supplied by publisher]
	SYHX1901, an oral dual JAK/SYK inhibitor, for moderate-to-severe plaque psoriasis: a randomized phase 2 trial. J Am Acad Dermatol Han L, Zhu L, Yu G, Cheng F, Cao L, Pei Z, Qin X, Mu K, Zhang S, Liang X, Li S, Ding Y, Zhu Q, Shi C, Man X, Kang X, Zhang F, Wu S, Xu J. PMID: 41419128 [PubMed - as supplied by publisher]
	Exploring shared diagnostic genes and molecular mechanisms in multiple sclerosis and psoriasis through bioinformatics analysis and machine learning. Biochem Biophys Res Commun Kong Y, Li X, Yang F, Wang J, Guo P, Ren C, Duan Z, Bi M, Wang Y, Liu F, Zhang Y. PMID: 41418349 [PubMed - as supplied by publisher]
	Beyond trauma: Schema-driven psychological burden in psoriasis. PLoS One Major J, Matuz A, Moezzi M, Lengyel Z, Birkás B, Gács B. PMID: 41417763 [PubMed - indexed for MEDLINE]
	Impact of weight-loss interventions on psoriasis severity: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol Morrow S, Hawkins P, Griffiths CEM, Tektonidis TG, Harriss E, Scragg J, Jebb S. PMID: 41416383 [PubMed - as supplied by publisher]
	Exploring the Role of Phytoconstituent From Euphorbia neriifolia Targeting IL-17A in Psoriasis: In Silico and InÂ Vitro Study. Food Sci Nutr Sharma N, Sahu SK, Verma P, Roy T, Garg SS, Vyas M, Sah AK. PMID: 41416116 [PubMed]
	IL-17 Class Inhibitors and Plaque Psoriasis: Not All Biologics Relapse Equally. J Clin Aesthet Dermatol Issa NT, Al-Tariq K, Bunick CG. PMID: 41416024 [PubMed]
	Sex-specific associations between nutritional status, disease activity, and fatigue in psoriatic arthritis: a cross-sectional analysis. Rheumatol Int Cilli Hay, Öz N, Duruöz MT. PMID: 41413697 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 27207

Page 1 of 1361



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy